Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × casopitant × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Vomiting 1 Neoplasms 1 Nausea 1 Lung Neoplasms 1

Interventions

Dexamethasone 3 Aprepitant 2 netupitant, palosentron drug combination 1 netupitant 1 fosaprepitant 1 casopitant 1 Yoga 1 Therapeutics 1 Radiotherapy 1 Palonosetron 1 Ondansetron 1 Olanzapine 1 Exercise 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

GlaxoSmithKline

Phase 3 Withdrawn

Lung Neoplasms, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡